Z Squared Inc. (ZSQR): who owns it and who trades it
As of Nov 3, 2026, ZSQR insiders reported 1 purchase worth $3.9K in the last 12 months. The largest buyer was Christopher Ryan Schadel (Chief Marketing Officer), with $3.9K.
Latest filing Nov 3, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who owns ZSQR
44 funds and institutions reported ZSQR shares worth $71.2M at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 40.5%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 2.52M | 40.51% | $26.7M | – |
| Vanguard Capital Management LLC | 1.67M | 26.84% | $17.7M | – |
| Geode Capital Management, LLC | 713,196 | 11.46% | $7.5M | – |
| Northern Trust Corp | 346,687 | 5.57% | $3.7M | – |
| Vanguard Portfolio Management LLC | 303,288 | 4.87% | $3.2M | – |
| Vanguard Fiduciary Trust Co | 128,391 | 2.06% | $1.4M | – |
| Nuveen, LLC | 104,189 | 1.67% | $1.1M | – |
| Charles Schwab Investment Management Inc | 103,522 | 1.66% | $1.1M | – |
| Sixth Street Partners Management Company, L.P. | 103,522 | 1.66% | $1.1M | – |
| Bank of New York Mellon Corp | 91,603 | 1.47% | $969K | – |
| United Capital Financial Advisors, LLC | 86,062 | 1.38% | $911K | – |
| UBS Group AG | 70,148 | 1.13% | $742K | – |
| Rhumbline Advisers | 49,649 | 0.80% | $525K | – |
| Deutsche Bank Ag\ | 43,667 | 0.70% | $462K | – |
| Wells Fargo & Company | 40,056 | 0.64% | $424K | – |
| T. Rowe Price Associates | 36,065 | 0.58% | $382K | – |
| Wellington Management Group LLP | 33,100 | 0.53% | $350K | – |
| MetLife Investment Management, LLC | 26,305 | 0.42% | $278K | – |
| Bank of America Corp | 25,189 | 0.40% | $266K | – |
| Invesco Ltd. | 23,857 | 0.38% | $252K | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, ZSQR insiders reported $3.9K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Christopher Ryan Schadel | Chief Marketing Officer | Purchase | 1,000 | $3.92 | $3.9K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Christopher Ryan Schadel | Chief Marketing Officer | $3.9K | – | Aug 18, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ZSQR short interest
Moderate short interest. 6.6% of ZSQR shares are sold short: about 1 share in 15. Over the last 12 reports the number of shares short went up 572%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 3.47M ZSQR shares were sold short, 6.6% of the shares outstanding, down 5.5% from the report before. At the average daily volume of 323,744 shares, buying them all back would take about 10.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 3.47M | 6.55% | -5% | 323,744 | 10.7 |
| Oct 15, 2026 | 3.67M | 6.93% | -19% | 513,248 | 7.2 |
| Sep 30, 2026 | 4.54M | 8.56% | +10% | 480,134 | 9.4 |
| Sep 15, 2026 | 4.11M | 7.76% | -1% | 405,841 | 10.1 |
| Aug 31, 2026 | 4.16M | 7.85% | -1% | 333,032 | 12.5 |
| Aug 14, 2026 | 4.21M | 7.95% | +5% | 369,996 | 11.4 |
| Jul 31, 2026 | 4.03M | 64.78% | +8% | 442,434 | 9.1 |
| Jul 15, 2026 | 3.75M | 60.21% | +121% | 686,566 | 5.5 |
| Jun 30, 2026 | 1.70M | 27.28% | +50% | 1.21M | 1.4 |
| Jun 15, 2026 | 1.13M | 18.16% | +80% | 279,068 | 4.0 |
| May 29, 2026 | 628,655 | 10.10% | +22% | 251,840 | 2.5 |
| May 15, 2026 | 516,958 | 8.31% | +9% | 169,270 | 3.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Z Squared company events
Z Squared filed 22 reports on Form 8-K in the last 12 months, 8 of them about an important change (leadership, control, listing). The latest was on Nov 3, 2026.
- Nov 3, 2026LeadershipUpon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Z Squared Inc., the Board elected Jeffery Harris, the Company’s Chief Technology Officer, as a director of the Company, effective November 3, 2026, to fill the vacancy on the Board created by… Filing
- Sep 14, 2026DealThe information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. Filing
- Sep 10, 2026RulesChanged its bylaws or articles. Filing
- Aug 26, 2026LeadershipAs previously reported, on June 24, 2026, Z Squared Inc. and Jeffery Harris, the Company’s Chief Technology Officer, entered into an Executive Employment Agreement, providing for an annual bonus in the form of restricted stock units having a grant-date fair market value equal to three times Mr.… Filing
- Aug 4, 2026AgreementAs previously disclosed, on June 18, 2026, Z Squared Inc. and Paradox Data, LLC, a Florida limited liability company, entered into a binding letter of intent contemplating the acquisition by the Company of a majority of the outstanding membership interests of Paradox Data. Filing
- Jul 22, 2026AgreementEnded an important agreement. Filing
- Jul 10, 2026AgreementAs previously disclosed, on April 28, 2026, Z Squared Inc., a Delaware corporation, entered into a binding letter of intent with MN Data Centers JV LLC, a Delaware limited liability company, and Claw Holdings, LLC, a North Carolina limited liability company, setting forth the principal terms and… Filing
- Jul 7, 2026AgreementZ Squared Inc., a Delaware corporation, entered into a Sales Agreement with Roth Capital Partners, LLC, pursuant to which the Company may offer and sell, from time to time, through or to the Agent, acting as the Company’s sales agent or principal, shares of the Company’s common stock, par value… Filing
- Jun 30, 2026LeadershipThe Board of Directors of Z Squared Inc. appointed Jeffery Harris as Chief Technology Officer of the Company, effective June 24, 2026. Filing
- Jun 29, 2026AnnouncementAs previously disclosed on November 1, 2024, the Company (then known as Coeptis Therapeutics Holdings, Inc.) entered into a Standby Equity Purchase Agreement with YA II PN, Ltd., a Cayman Islands exempt limited company, pursuant to which the Company had the right, from time to time at its election… Filing
- Jun 26, 2026AgreementZ Squared Inc., a Delaware corporation, entered into a binding Letter of Intent with Paradox Data LLC and the holders of the membership interests of Paradox, pursuant to which the Company proposes to acquire a majority membership interest in Paradox. Filing
- Jun 4, 2026AgreementZ Squared Inc. entered into a Committed Equity Forward Purchase Agreement with LucentHash / Data Part Capital, a trading name of Translucent Matter Inc., a British Virgin Islands company. Filing
- May 22, 2026LeadershipResignation of Co-Chief Executive Officer and Director. Filing
- May 21, 2026AnnouncementShared information with investors. Filing
- May 1, 2026LeadershipResignation of Directors and Officers Effective as of the effective time of the previously announced merger of CP Merger Sub, Inc., a wholly-owned subsidiary of the Company, with and into Z Squared Opco, Inc. (formerly Z Squared, Inc.) on April 27, 2026, each of the directors and officers of the… Filing
- Apr 30, 2026ControlChanges in Control of the Registrant Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01 Financial… Filing
- Apr 28, 2026AnnouncementZ Squared, Inc.(NASDAQ: ZSQR) (the Company”) issued a press release supplementing information related to its recently announced business combination with Coeptis Therapeutics Holdings, Inc. and its pro rata dividend distribution related to Coeptis Therapeutics Holdings, Inc.’s pre-business… Filing
- Apr 24, 2026AnnouncementShared information with investors. Filing
- Apr 8, 2026AnnouncementCoeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) issued a press release announcing that Nasdaq has approved, subject to customary conditions and the closing of the proposed merger with the Company and Z Squared Inc., the listing of the post-merger Company’s common stock on the Nasdaq Global… Filing
- Feb 12, 2026LeadershipCoeptis Therapeutic Holdings, Inc. implemented an option repricing/exchange program pursuant to Option Repricing and Exchange Election Agreements (the Option/Exchange Agreements) with its then current holders of options previously granted under the Company’s 2022 Equity Incentive Plan, including… Filing
- Feb 4, 2026VoteReported shareholder vote results. Filing
- Jan 16, 2026ListingCoeptis Therapeutics Holdings, Inc. received a letter from the Listing Qualifications Department of The Nasdaq Capital Market LLC indicating that the Company is in violation of Nasdaq Listing Rules 5620(a) and 5810(c)(2)G) due to the Company’s failure to hold an annual meeting of shareholders… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Z Squared financials
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named ZSQR in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 27, 2026 | BlackRock, Inc. | 13G | 5.1% |
| Oct 27, 2026 | BlackRock, Inc. | 13G | 5.1% |
Questions about Z Squared Inc. (ZSQR) stock
Who owns the most ZSQR stock?
The largest reported owner of Z Squared Inc. (ZSQR) is BlackRock, Inc., with 40.5% of the company. In total, 44 funds and institutions reported holding ZSQR at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are ZSQR insiders buying or selling?
In the last 12 months, ZSQR insiders reported 1 open-market purchase worth $3.9K and no sales. The latest trade was on Aug 18, 2026. See every trade.
What is the short interest in ZSQR?
As of Oct 30, 2026, 3.47M ZSQR shares were sold short, 6.6% of the shares outstanding, down 5.5% from the report before. At the average daily volume of 323,744 shares, buying them all back would take about 10.7 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.